SRI-29329

Overview

SRI-29329 is a specific CLK inhibitor, with IC 50 values of 78 nM, 16 nM and 86 nM for CLK1, CLK2 and CLK4, respectively.

Application

Products | Products > Disease Areas > Ovarian Cancer | Products > Disease Areas > Urogenital Cancer | Products > Disease Areas > Cancer | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Urogenital Disease | Products > Disease Areas > Breast Cancer | Products > Disease Areas > Leukemia/Lymphoma/Myeloma | Products > Disease Areas > Blood Disease | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Research Areas > Others | Products > Signaling Pathways > CDK

Product Information

• Catalog No.: HY-123600
• CAS No.: 2086809-58-5
• Molecular Formula: C20H26ClN7
• Molecular Weight: 399.92
• Purity: 99.14%
• Storage: Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: 2.5 mg/mL (6.25 mM); Suspended solution; Need ultrasonic
• Availability: In-stock

Source

Original product source